General Information of the Compound
Compound ID
CP0044878
Compound Name
1-(3,5-Di-tert-butyl-4-hydroxy-phenyl)-hex-5-yn-1-one
    Show/Hide
Synonyms
1-(3,5-di-tert-butyl-4-hydroxyphenyl)hex-5-yn-1-one
1-(3,5-ditert-butyl-4-hydroxyphenyl)hex-5-yn-1-one
112018-00-5
3',5'-Di-tert-butyl-4'-hydroxy-5-hexynophenone
5-Hexyn-1-one, 1-(3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)-
5-Hexyn-1-one, 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-
AC1L1TG2
AC1Q5DB7
CHEMBL13878
NE 11740
NE-11740
O048K9ZFHO
SCHEMBL43674
TEBUFELONE
Tebufelona
Tebufelona [INN-Spanish]
Tebufelone
Tebufelone (USAN/INN)
Tebufelone [USAN:INN]
Tebufelonum
Tebufelonum [INN-Latin]
UNII-O048K9ZFHO
    Show/Hide
Structure
Formula
C20H28O2
Molecular Weight
300.442
Canonical SMILES
CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(=O)CCCC#C
    Show/Hide
InChI
InChI=1S/C20H28O2/c1-8-9-10-11-17(21)14-12-15(19(2,3)4)18(22)16(13-14)20(5,6)7/h1,12-13,22H,9-11H2,2-7H3
    Show/Hide
InChIKey
ZHXUEUKVDMWSKV-UHFFFAOYSA-N
CAS
112018-00-5
Physicochemical Property
logP
4.9734
Rotatable Bonds
4
Heavy Atom Count
22
Polar Areas
37.3
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 60542
SID: 14751737
ChEMBL ID
CHEMBL13878
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01743, Polyunsaturated fatty acid 5-lipoxygenase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000194 RBL-1 Rattus norvegicus (Rat)  1
1
IC50 = 3000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( TEBUFELONE )
Drug Name TEBUFELONE
Indication
Pain
Discontinued in Phase 2
Target(s)
Prostaglandin G/H synthase 1 (COX-1)
Inhibitor
Prostaglandin G/H synthase 2 (COX-2)
Inhibitor
Arachidonate 5-lipoxygenase (5-LOX)
Inhibitor
LOX-5 messenger RNA (ALOX5 mRNA)
Inhibitor